Chaired by Vivian Yin and Navdeep Nijhawan.

This co-developed symposium features four expert panelists showcasing the full spectrum of treatment approaches, from trusted traditional methods to cutting-edge biologics. Expect lively discussions, structured presentations, and interactive Q&A sessions, expertly moderated by Dr. Yin and Dr. Niijhawan. 

Breakfast will be served from 6:30 - 7:00 AM.

Learning Objectives

At the end of this session, participants will be able to:

1. To differentiate the different pathway targets for thyroid eye disease treatment.
2. To compare the efficacy of the different treatment modalities for TED.
3. To contrast the side effect of the different treatment modalities for TED.

CanMEDS: Scholar, Health Advocate, Medical Expert, Collaborator, Communicator, Leader

This session was co-developed by The Canadian Ophthalmological Society and Amgen and was planned to achieve scientific objectivity and balance.